{"id":"https://openalex.org/W4388048343","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1178","title":"1178 Tumor-immune cell targeting chimeras (TICTACs): targeted immune reprogramming of the tumor microenvironment","display_name":"1178 Tumor-immune cell targeting chimeras (TICTACs): targeted immune reprogramming of the tumor microenvironment","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388048343","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1178"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1178","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1178","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1178","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1298.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1298.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Mariko Morimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariko Morimoto","raw_affiliation_strings":["Stanford University, Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Menlo Park, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048268641","display_name":"Nicholas A. Till","orcid":"https://orcid.org/0000-0003-2421-7186","observed_orcids":["https://orcid.org/0000-0003-2421-7186"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas A Till","raw_affiliation_strings":["Stanford University, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Stanford, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088409133","display_name":"Carolyn Ruth Bertozzi","orcid":"https://orcid.org/0000-0003-4482-2754","observed_orcids":["https://orcid.org/0000-0003-4482-2754"]},"institutions":[{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carolyn R Bertozzi","raw_affiliation_strings":["Stanford University, Stanford, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford University, Stanford, CA, USA","institution_ids":["https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I97018004"],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A1298","last_page":"A1298"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6615999937057495,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.6615999937057495,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.2888000011444092,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.01979999989271164,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cd206","display_name":"CD206","score":0.9470000267028809},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.6179999709129333},{"id":"https://openalex.org/keywords/sirpalpha","display_name":"SIRP\u03b1","score":0.8169999718666077},{"id":"https://openalex.org/keywords/icam-1","display_name":"ICAM-1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/antibody-conjugates","display_name":"antibody conjugates","score":0.7559999823570251},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6840000152587891},{"id":"https://openalex.org/keywords/macrophage-polarization","display_name":"macrophage polarization","score":0.5669999718666077},{"id":"https://openalex.org/keywords/il-4","display_name":"IL-4","score":0.5450000166893005},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.5630000233650208},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.35100001096725464},{"id":"https://openalex.org/keywords/tumor-specific-immunotherapy","display_name":"tumor-specific immunotherapy","score":0.41200000047683716}],"concepts":[{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.7051064968109131},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.6574720144271851},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5918303728103638},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.542395830154419},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4717603325843811},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4526800513267517},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.37515637278556824},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.37448930740356445},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3401499390602112}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.1178","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1178","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1178","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1298.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:2b8b15f9082447cbb95bac98faf0631e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/2b8b15f9082447cbb95bac98faf0631e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.1178","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.1178","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.1178","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/1298.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388048343.pdf","grobid_xml":"https://content.openalex.org/works/W4388048343.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389408709","https://openalex.org/W7167733389","https://openalex.org/W7168383282","https://openalex.org/W4415135075","https://openalex.org/W2964377482","https://openalex.org/W7172382803","https://openalex.org/W4416372920","https://openalex.org/W4320486314","https://openalex.org/W4404065345","https://openalex.org/W7214907819"],"abstract_inverted_index":{"Background":[0],"The":[1,367],"immune":[2,43,94],"cells":[3],"in":[4,37,236,261,323,398],"the":[5,124,135,148,151,179,209,231,234,237,251,294,300,305,312,324,342,373],"tumor":[6],"microenvironment":[7],"(TME)":[8],"are":[9,89,330],"not":[10,122,256],"only":[11,322],"powerful":[12],"regulators":[13],"of":[14,33,91,102,147,153,178,211,225,233,247,253,259,269,299,307,314,326,339,344,376],"immunosuppression":[15],"and":[16,114,138,171,186,194,208,213,220,241,272,297,319,335,385],"tumorigenesis,":[17],"but":[18,120,255],"also":[19,317],"represent":[20],"a":[21,65,103,110,115,262,358],"dominant":[22],"cell":[23,35,53,190],"type,":[24],"with":[25,199,206],"tumor-associated":[26],"macrophages":[27,260,278],"(TAMs)":[28],"comprising":[29],"up":[30],"to":[31,182,201,229,304],"50%":[32],"total":[34],"mass":[36],"solid":[38],"tumors.":[39],"Immunotherapies":[40],"such":[41],"as":[42,281,283],"checkpoint":[44,95],"inhibitors":[45],"(ICIs)":[46],"derive":[47],"their":[48],"efficacy":[49,313],"from":[50,61,150,352,372],"this":[51,71,356,399],"cancer-immune":[52],"interface,":[54],"however,":[55],"auto-immune":[56],"related":[57],"adverse":[58],"events":[59],"resulting":[60],"systemic":[62],"administration":[63],"remain":[64],"significant":[66,337],"challenge.":[67],"Methods":[68],"To":[69],"address":[70],"need":[72],"for":[73,333,361],"potent,":[74],"yet":[75],"highly":[76,363],"tumor-specific":[77,364],"immunotherapies,":[78],"we":[79,140],"developed":[80],"Tumor-Immune":[81],"Cell":[82],"Targeting":[83],"Chimeras":[84],"(TICTACs),":[85],"antibody":[86,117,350],"conjugates":[87],"that":[88,118,142],"capable":[90],"selectively":[92],"inhibiting":[93],"(ICP)":[96],"molecules":[97],"on":[98,160,250,276,310,341],"TAMs.":[99],"They":[100],"consist":[101],"novel":[104],"synthetic":[105],"ligand":[106,181,296],"which":[107,131],"recognizes":[108],"CD206,":[109,130],"well-established":[111],"TAM":[112],"marker,":[113],"non-blocking":[116],"binds":[119],"does":[121],"inhibit":[123],"ICP":[125,149],"(figure":[126,265],"1).":[127],"By":[128,348],"engaging":[129],"constitutively":[132],"recycles":[133],"between":[134],"plasma":[136],"membrane":[137],"endosomes,":[139],"envisioned":[141],"TICTACs":[143,164,243,315,329],"could":[144],"facilitate":[145],"removal":[146],"surface":[152,252,343],"CD206high":[154,277,346],"TAMs,":[155],"while":[156],"having":[157],"no":[158],"effect":[159],"healthy":[161],"CD206low":[162,257],"macrophages.":[163],"against":[165],"signal":[166],"regulatory":[167],"protein":[168],"alpha":[169],"(SIRPa)":[170],"CD54":[172,187,214,242,273],"were":[173,196,215,274,396],"constructed":[174],"through":[175],"non-specific":[176],"conjugation":[177],"CD206":[180,203,226,288,308,334],"commercially":[183],"available":[184],"anti-SIRPa":[185],"antibodies.":[188],"Macrophage":[189],"lines":[191],"RAW264.7,":[192],"J774A.1,":[193],"BMA3.1A7":[195],"first":[197],"dosed":[198],"IL-4":[200],"induced":[202],"expression,":[204],"treated":[205],"TICTACs,":[207],"levels":[210],"SIRPa":[212,271],"assessed":[216],"by":[217,293],"flow":[218],"cytometry":[219],"confocal":[221],"microscopy.":[222],"CRISPR/Cas9":[223],"knockout":[224],"was":[227],"performed":[228],"validate":[230],"involvement":[232],"receptor":[235],"mechanism.":[238],"Results":[239],"Anti-SIRPa":[240],"enabled":[244],"robust":[245],"downregulation":[246,298,320,338],"these":[248],"proteins":[249],"CD206high,":[254],"populations":[258],"dose-dependent":[263],"manner":[264],"2).":[266],"Significant":[267],"decrease":[268],"both":[270,290],"observed":[275],"at":[279],"doses":[280],"low":[282],"1":[284],"nM.":[285],"Knocking":[286],"out":[287],"abrogated":[289],"uptake":[291],"mediated":[292],"CD206-targeting":[295],"target":[301],"ICP.":[302],"Due":[303],"dependence":[306],"expression":[309],"IL-4,":[311],"is":[316],"cytokine-dependent,":[318],"occurs":[321],"presence":[325],"IL-4.":[327],"Conclusions":[328],"selective":[331],"binders":[332],"mediate":[336],"ICPs":[340],"tumor-associated,":[345],"cells.":[347],"decoupling":[349],"selectivity":[351],"its":[353],"blocking":[354],"function,":[355],"presents":[357],"new":[359],"paradigm":[360],"developing":[362],"immunotherapies.":[365],"Acknowledgements":[366],"authors":[368],"gratefully":[369],"acknowledge":[370],"support":[371],"National":[374],"Institute":[375],"Health":[377],"(Award":[378],"no.":[379],"GM058867),":[380],"Howard":[381],"Hughes":[382],"Medical":[383],"Institute,":[384],"Stanford":[386],"University.":[387],"Ethics":[388],"Approval":[389],"No":[390],"human":[391,394],"subjects":[392],"or":[393],"data":[395],"used":[397],"study.":[400]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}